Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 2/20 | 0.30 |
| ▸ | DAO | P14920 | 1/20 | 0.30 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.30 |
| ▸ | CES2 | O00748 | 1/20 | 0.30 |
| ▸ | CES1 | P23141 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19085444 | 0.84 | AKT1 (0.38) | AKT1ALDH1A1MAPK1TDP1TSHR | |
| SCHEMBL19085533 | 0.82 | AKT1 (0.36) | AKT1 | |
| SCHEMBL21864739 | 0.81 | SMN1; SMN2 (0.35) | ALDH1A1NAPRT | |
| SCHEMBL23011270 | 0.79 | PARP1 (0.40) | ALDH1A1MAPK1TDP1 | |
| SCHEMBL21346624 | 0.79 | ALDH1A1 (0.41) | ALDH1A1 | |
| SCHEMBL21098282 | 0.76 | TP53 (0.49) | ALDH1A1MAPK1TDP1TSHR | |
| SCHEMBL28240816 | 0.73 | AKT1 (0.48) | AKT1ALDH1A1MAPK1TDP1TSHR | |
| SCHEMBL22482868 | 0.72 | AKT1 (0.38) | AKT1ALDH1A1MAPK1TDP1TSHR | |
| SCHEMBL12177014 | 0.72 | ESR1 (0.35) | AKT1ALDH1A1TDP1TSHR | |
| SCHEMBL24336641 | 0.69 | DEGS1 (0.31) | AKT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10892426-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2021-01-12 | — | — | US | disclosed |
| US-20200152890-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2020-05-14 | — | — | US | disclosed |
| US-10593896-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-03-17 | — | — | US | disclosed |
| US-20190225635-A1 | METAL COMPLEXES CONTAINING SUBSTITUTED PYRIDINE LIGANDS | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2019-07-25 | — | — | US | disclosed |
| US-20190148651-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2019-05-16 | — | — | US | disclosed |
| US-9630983-B2 | Organic electroluminescent material and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2017-04-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200152890-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, LMNB2, RUVBL2 | AKT1 4093/4885ALDH1A1 2215/4885MAPK1 3421/4885 |
| US-20190225635-A1 | METAL COMPLEXES CONTAINING SUBSTITUTED PYRIDINE LIGANDS | SOD1, TRPC6, NDUFS8 | AKT1 4153/4885ALDH1A1 1016/4885MAPK1 1297/4885 |
| US-10892426-B2 | Organic electroluminescent materials and devices | OCIAD2, LMNB2, RUVBL2 | AKT1 4093/4885ALDH1A1 2215/4885MAPK1 3421/4885 |
| US-20190148651-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | TYR, DDT, EML4 | AKT1 4249/4885ALDH1A1 368/4885MAPK1 1396/4885 |
| US-10593896-B2 | Organic electroluminescent materials and devices | TYR, DDT, EML4 | AKT1 4249/4885ALDH1A1 368/4885MAPK1 1396/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.